chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from other company (Pfizer) via a patient concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypothyroidism. The patient was not having any drug allergy. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, administered 1 in total to the left arm on 09-APR-2021 for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received non-company suspect vaccine included: tozinameran (Pfizer vaccine) (Dose number in series 2) (form of admin, route of admin, batch number and expiry were not reported) dose was not reported, administered to the left arm on 03-DEC-2021 for covid-19 prophylaxis. No concomitant medications were reported. On 03-DEC-2021, the patient had revaccination with different covid-19 vaccine. On an unspecified date, the patient experienced suspected covid-19 infection. Laboratory data (dates unspecified) included: COVID-19 virus test Negative. The patient received non-company co-suspect drug Paxlovid (form of administration, route of administration, batch number, and expiry were not reported) dose was not reported, administered from 18-SEP-2022 to 23-SEP-2022 for treatment of COVID-19.  On an unspecified date ,the patient experienced Itchy throat, nasal congestion, and cough began 15 days after testing negative and finishing paxlovid anti viral pills. The action taken with covid-19 vaccine ad26.cov2.s, tozinameran was not applicable, and with Paxlovid was drug discontinued. The patient had not recovered from suspected covid-19 infection, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.
allergic reaction; Tingling on tongue and it swells up; Tingling on tongue and it swells up; Hard to swallow; have a rash on my neck, it was on my face and all over up to my chest; This is a spontaneous report from a contactable consumer (patient). A 57-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER8737), via an unspecified route of administration, administered in Arm Left on 18Jun2021 (at age of 57 years old) as single dose for COVID-19 immunization. Medical history included Discoid lupus erythematosis, Hypothyroidism. Concomitant medications included levothyroxine sodium (SYNTHROID); famotidine (PEPTID); vitamin d [vitamin d nos]; vitamin b nos; calcium; calcium carbonate, sodium fluoride (FLORICAL).  No Prior vaccination (Within 4 weeks). Consumer stated, I got the vaccine on Friday and I had an allergic reaction. I had tingling on my tongue and it swells up and it was hard to swallow and I had to go to the emergency room. Consumer stated, I have a rash on my neck, it was on my face and all over up to my chest. (Not clarified further), All on 18Jun2021 5:30 pm and were medically significant. Treatment for event (went to the ER and they gave Benadryl and Prednisone). Patients outcome of the events was unknown.
Headache, left facial/mouth/eye droop, left eye teary, mild oral drooling, decreased left cheek sensation
fully vax COVID + 12/27/21 dose 1 12/28/2020 dose 2 1/18/2021
Had severe migraines.; Also body aches all over the body; Allergic reaction in the face; swelling mouth, nose and ears; swelling mouth, nose and ears; swelling mouth, nose and ears; Rapid heartbeats; This is a spontaneous report from a contactable consumer (patient).  A 30-years-old non pregnant female patient received BNT162B2 (Batch/Lot number was not reported), via an unspecified route, administered in Left Arm on 22Aug2021 (Age at vaccination 30 year, non-pregnant) as dose 1, single, and via an unspecified route, administered in Left Arm on 22Aug2021 (Age at vaccination 30 year, non-pregnant) as dose 2, single for covid-19 immunisation.  The patient medical history was not reported. The patient did not have known allergy. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient diagnosed with COVID-19 prior to vaccination and has the patient been tested for COVID-19 Since the vaccination. There were no concomitant medications.  On 22Aug2021 the patient experienced had severe migraines, also body aches all over the body, allergic reaction in the face, swelling mouth, nose and ears and rapid heartbeats. The outcome of the events was recovering.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Headaches, nausea and  dizziness within 45 minutes of vaccine.  Inability to lift right arm, swelling at injection site with pain radiating to underarm and left breast area.  Generalized weakness and body aches with severe back pain.  Fever and chills started 12 hours after vaccination with 101.3 high and down to 99.5 after 48 hours.  3rd day today swelling in left arm and inability to do normal chores with left hand.  Pain in the neck and back.    Feeling of being punched at the injection site, swelling, hard and blue at area of injection.
Pt recvd vax 28APR92 & exp swelling of ankle, joint warm & mildly painful; pos rheumatoid factor, morning stiffness, rheumatoid arthritis, joints showed mild swelling; tenderness & warmth in lt ankle as well as pain upon motion;
40 year old female 10 minutes after the first dose Moderna vaccine started complaining of L side facial numbness. Denies any Allergies. Medical history includes hypothyroidism which she takes Synthroid. Pt was taken to the observation room, vital sign 158/92, 96, 16, 99%.  Alert, and Oriented. No wheezing, or stridor. Decrease sensation to L side of face. While in the observation room, patient started complaining of L hand numbness. 911 was called. No medication giving. Pt transferred to the Emergency Room.
Patient with long-COVID myocarditis (1 year) experienced an improvement in symptoms after third dose (booster dose) of Pfizer COVID vaccine.; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: Patient with long-COVID myocarditis (1 year); "myocarditis" (unspecified if ongoing), notes: Patient with long-COVID myocarditis (1 year). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunization; Bnt162b2 (Dose 2), for Covid-19 immunization. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "Patient with long-COVID myocarditis (1 year) experienced an improvement in symptoms after third dose (booster dose) of Pfizer COVID vaccine.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After my second shot of moderna, I felt okay but towards the night I felt very restless. I looked up if restlessness is a side affect of the shot but I didn?t come up with anything. It said fatigue which I had after the first shot but this one I didn?t fall asleep until 5:30 AM. I also had cramps like period cramps as if my lungs dropped to my pelvic.
Patient has swelling & tenderness & pain on the arm where flu shot was administered. Symptoms started couple of days after shot.
In the evening of the day flu vaccine given, Mom reported patient "felt very hot" but temperature was not taken. Per Mom pt's left leg began to swell at injection site 24 hours after vaccine received.
Patient reports chest tightness, pain is 5/10, EMS assessed patient and performed EKG (normal), BP: 217/108, second reading 178/101, pulse:85,  patient reports chest pain continues 4-5/10 , Patient was transported to emergency room by ambulance.
Symptoms began on 10/26/22, patient complains of arthritic, painful joints, mostly in the hips and knees, pain continues to progress through today 10/27/22.  Patient has taken acetaminophen, but no relief from that.
Right upper arm became red, hot, swollen where Varicella vaccine was given. Area of redness spread >1 inch over 24hrs. Patient taken to Emergency Room & was diagnosed with staph infection/cellulitis per mom. Prescribed BACTRIM and KEFLEX for 7 days. Symptoms resolved 5 days after onset.
A physician report from a medical representative concerns a 24 month old male. The patient had history of seizures and cerebral palsy since he was born. Concomitant medications were not provided. On 03-Nov-2009 the physician administered FLUMIST (intranasal) to the patient. On 10-Nov-2009 the patient was hospitalized for pneumonia. After a couple of weeks patient recovered from pneumonia but remained hospitalized due to complications with underlying condition. The physician was being sued by the parent. The reporter assessed the event as non-serious with additional criteria of required emergency room/ doctor visit. The company physician upgraded the event to serious due to hospitalization.
This is a spontaneous report from a contactable physician sales representative. This physician reported similar events for four patients. This is 2nd of 4 reports. An adolescent (Age: 16-17) patient of an unspecified ethnicity and gender received TRUMENBA, via an unspecified route of administration on an unspecified date, at single dose. The patient medical history and the patient's concomitant medications were not reported. The patient experienced arm pain, swelling and fever, all on an unspecified date with outcome unknown.
Minor itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Minor itching at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Minor itching at injection site). At the time of the report, VACCINATION SITE PRURITUS (Minor itching at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
took the whole Covid test and one came out negative and the other came out positive; getting sick; This is a spontaneous report from a contactable 19-year-old female consumer reported for herself. A 19-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 17Sep2021 (Batch/Lot number was not reported) as dose 1, single (age at vaccination 19-year-old) for covid-19 immunisation. Medical history included None. There were no concomitant medications. The patient experienced took the whole covid test and one came out negative and the other came out positive (covid-19) and getting sick on an unknown date in Sep2021. The patient underwent lab tests and procedures which included sars-cov-2 test one came out negative on an unknown date in Sep2021, sars-cov-2 test: the other came out positive on an unknown date in Sep2021 (took the whole Covid test and one came out negative and the other came out positive). The outcome for all events was unknown.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Last part of vaccine sent a tingling feeling down my arm to my middle finger. Once the needle was out it stopped. Came home and iced the area once. 5:15 pm first chills started. Went away after I drank hot tea. Headache started and stayed the rest of the night until next morning. Also at 5:15 started the achy body feeling, my joints hurt. I have a total knee replacement on the right side and it ached. I had a hard time to walk up and down the steps in our house. I was suddenly real tired. Went to bed at 9:00 pm exhausted and feeling nauseated. Slept until 11:15 pm when I woke up to my teeth chattering. Put wool socks and sweater on and extra blanket. Fell back to sleep. Woke up at 7:00 am felt better,  but after being up a short time I felt  off. Took a nap at noon because I became real tired. Slept until 2 that afternoon (now Friday day after injection) and woke up feeling like myself.  Saturday I felt fine. Sunday I woke up to a cold sore on my lip. Tender to  the touch at the injection site but nothing by Sunday.
Patient had no discomfort following vaccination until 2 days later on 2/5. She began to have extreme pain, a hard knot, and redness at the injection site. On 2/6, she had diarrhea, altered vision in the right eye. and "face hung down" Symptoms lasted about 36 hours. By Monday 2/8/2021, symptoms were completely resolved with no residual effect.
About 2 minutes after giving patient the vaccination, he started to have a tingling , numbness down the left  arm to the fingers. Then patient started to break out in a sweat, almost like a panic attack. He felt very nauseous but never vomited. He told me that he doesn't get panic attacks but is very nervous about getting shots. I gave him cold water and put an ice pack behind his neck. He did sweat through  his T-shirt. You could clearly see it.  This lasted about 7 minutes. about the 11th minute sweating stopped. After 4 more minutes he felt fine and the sweating had stopped. He was just a little nauseous when he left. After I asked if he needed a ride, he assured me that he felt fine to drive too.
This spontaneous report was received from a healthcare worker regarding a patient of unknown age and gender. Patient's medical history, concurrent conditions, and concomitant medications were not provided. On 12-MAY-2016, the patient was vaccinated with an expired dose of ROTATEQ, (lot # K001832, expiry date: 20-NOV-2014) (route, dose and frequency not reported). No adverse effect reported. No product quality (PQC) involved. No further information provided. Additional information has been requested.
Pt recv vax 05MAY98 on 06MAY98 pt exp a local reaction described as a large, red, sore, swollen, hard, warm area approx 3X3 inches with some red streaks under her arm
Severe nausea, severe headache, extreme arm pain, extreme fatigue, extreme brain fog for the first 4 days.   Brain fog , fatigue and nausea continued through 8/25/2021.  When the person gave me the shot, the first stick she said ?uh oh? and then immediately stuck me again. The injection sight was very bloody and painful.
severe runny nose; chills; light headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 19Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHINORRHOEA (non-serious) with onset 03Mar2021, outcome "unknown", described as "severe runny nose"; CHILLS (non-serious) with onset 03Mar2021, outcome "unknown", described as "chills"; HEADACHE (non-serious) with onset 03Mar2021, outcome "unknown", described as "light headache". Therapeutic measures were taken as a result of rhinorrhoea, chills, headache.  Additional information: Patient received Pfizer Covid-19 vaccine first dose on 19Feb2021, 2 weeks after 1st dose on 03Mar2021 patient experienced chills, light headache and severe runny nose for 2 days. She took amoxicillin and antihistamine. Patient was advised to take the Covid-19 test and wait for the result until 12Mar2021 (reported as tomorrow) which on that day was her return day to take the 2nd dose. Patient wanted to know if she need to take the 2nd dose or need to wait for the result first prior to taking the 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient describes inflammation, redness, and swelling at the injection site. She says that it was warm to the touch and lasted for a full 7 days.
NEUROPATHY LEFT HAND AND FINGERTIPS BUT NO DISCOLORATION OR LOSS OF TEMPERATURE OR PULSE; HORRIBLE TASTE IN MOUTH; MOUTH CONSTANTLY FEELS LIKE FUZZ IN IT; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency one total dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. Around 25-MAR-2021 patient received Vaccine, after vaccination she experience horrible taste in mouth, also neuropathy left hand fingertips with no discoloration or loss of temperature or pulse. Her mouth constantly feels like fuzz in it. Her sense of smell was perfect. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the horrible taste in the mouth, neuropathy left hand and fingertips but no discoloration or loss of temperature or pulse and mouth constantly feels like fuzz in it was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210516652-covid-19 vaccine ad26.cov2.s-neuropathy left hand and fingertips but no discoloration or loss of temperature or pulse. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Breast cancer.  Received first dose in left arm on April 26, 2021 with no signs or symptoms. On May 6, noticed an increase in size of my right breast and tender lymph nodes in my right arm pit. May 10 I was seen by my gynecologist and immediately recommended to have a mammogram. May 12 I had the mammogram, May 13 a biopsy was done. May 19 I was verbally told I had inflammatory mammary carcinoma.
fever up to 102.3, headache, chills, nausea, dizziness, body aches, weakness
This case was reported by a physician via sales rep and described the occurrence of influenza-like symptoms in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, fever and myalgia. On an unknown date, the outcome of the influenza-like symptoms, fever and myalgia were unknown. It was unknown if the reporter considered the influenza-like symptoms, fever and myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The healthcare professional reported that, the patient experienced flu-like symptoms, myalgia and fever. The reporter did not have any additional information. The medical representative sated that, this event was reported to him by the healthcare professional on 29th August 2018 and he submitted it on Wednesday however, the report was hung in email and he do not believe it went through. The reporter stated that he noticed, that it had not gone through so wanted to call agency to report the event. This case was one of the 2 cases, reported by the same reporter.
Patient came in about 5 weeks after the vaccine and described to pharmacist her reaction. Patient states she had a "screaming" headache that started at midnight after her vaccine. The headache lasted for two days.
Intussusception 4/13/07 Received hospital d/c summary & vax record from PCP/reporter which reveals patient admitted overnight 3/27-3/28/07 s/p air contrast enema reduction of ileal colonic IS. Unable to reduce initially & patient had gen anesthesia.  That relaxation allowed reduction.. FINAL DX: Ileal colonic IS, reduced by air contrast enema under gen anesthesia.
tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported. The patient was due for second vaccine on 22-Feb-2021.   Reporter did not allow further contact
pt recv vax; nausea devel; vomited once;metallic taste in mouth; pain and redness mild at injection site; entire upper lt arm erymatous, warm with induration 10x10;
SkinRash Narrative:  skin rash appeared all over the body 1 week after 1st vaccine injection that lasted 4 days. called personal physician for direction, and was advised to apply topical Benadryl and to stay for a 30 minutes observation for 2nd dose.
high pitched crying for more than 3hr;temp (how high not known) could feel was very hot;tx called MD was told to give APAP & tried to calm pt by rocking but did not help-lasted for more than 4 hr;pt has low IQ;
Developed shingles 10 days after 2nd dose was received.  Diagnosed 3/11/2021 and prescribed Famciclovir @ Dr. office.
headaches that started 2 weeks after the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (headaches that started 2 weeks after the vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches that started 2 weeks after the vaccine). At the time of the report, HEADACHE (headaches that started 2 weeks after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products were not provided Treatment medication were not reported   Reporter did not allow further contact